Brief: Medicenna Reports Third Quarter Fiscal 2022 Financial Results And Operational Highlights
09/02/2022 12:12
Feb 9 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* MEDICENNA THERAPEUTICS CORP - QTRLY LOSS PER SHARE $0.09
Source text for Eikon: ID:nGNX3QhMBY
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results